A human trial of a hepatitis C treatment is shut down after one of the participants died.
Advertisement
The Scientist
Most Recent
The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
Competition for resources between mothers- and daughters-in-law having children at the same time could have been a driver for the emergence of menopause.
A polar bear in a German zoo dies after contracting a virus normally found in zebras.
A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Researchers have found an increase in butterflies with unusual wing shapes, legs, and antennae than before the nuclear disaster.
The root system of a tree species is genetically different than the leaves of that individual, potentially modifying scientists’ understanding of evolution.
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
Researchers analyzing the bacteria in municipal drinking water find simple measures can increase beneficial bacteria while reducing pathogenic strains.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
